2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Zugas, Ines, Tormo-Ratera, Marta, Oliver-Caldes, Aina, Soler-Perromat, Juan Carlos, Gonzalez-Calle, Veronica, Moreno, David F., Cabanas, Valentin, Lopez-Munoz, Nieves, Bartolome-Solanas, Alvaro, Espanol-Rego, Marta, Reguera-Ortega, Juan Luis, Rosinol, Laura, Lopez-Corral, Lucia, Tovar, Natalia, Rodriguez-Lobato, Luis Gerardo, Perez, Rosa Maria Alvarez, Varea, Sara, Olesti, Eulalia, Gomez-Grande, Adolfo, Frutos, Laura, Tamayo, Pilar, Juan, Manel, Moraleda, Jose M., Urbano-Ispizua, Alvaro, Gonzalez-Navarro, E. Azucena, Martinez-Lopez, Joaquin, Mateos, Maria-Victoria, Tomas, Xavier, Setoain, Xavier, de Larrea, Carlos Fernandez. Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma. BLOOD ADV 9 571-582. 11 feb 2025. . . F.I.:7,400 [doi:10.1182/bloodadvances.2024014360]
Zabaleta, A, Puig, N, Cedena, MT, Oliver-Caldes, A, Perez, JJ, Moreno, C, Tamariz-Amador, LE, Rodriguez-Otero, P, Prosper, F, Gonzalez-Calle, V, López-Corral, L, Rey-Búa, B, Puertas, B, Mirás, F, Sánchez-Pina, J, López-Muñoz, N, Juan, ME, González-Navarro, E, Urbano, A, de Larrea, C, Blade, J, Lahuerta, JJ, Martinez-Lopez, J, Mateos, MV, San Miguel, JF, Paiva, B. Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T-cell redirecting immunotherapy. AM J HEMATOL 100 93-102. 1 ene 2025. 1 nov 2024. . F.I.:10,100 [doi:10.1002/ajh.27526]